drugset / Trial / NCT03320434
Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate the efficacy and safety of two concentrations of PRT-2761 as a topical ophthalmic solution for the treatment of the signs and symptoms of acute and chronic allergic conjunctivitis.
Timeline
- Start
- 2017-10-13
- Primary completion
- 2018-02-16
- Completion
- 2018-02-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Olopatadine | Other / unclassified | — | Topical |
| Subject | PRT-2761 | Unknown | 0.5 % | Topical |
| Subject | PRT-2761 | Unknown | 1 % | Topical |
| Comparator | Prednisolone | Other / unclassified | — | Topical |